ShareThis Page
Common anti-inflammatory drug doubles risk of heart attack or stroke, study finds |

Common anti-inflammatory drug doubles risk of heart attack or stroke, study finds

Patrick Sison/AP

Many people reach for painkillers to get rid of headaches or reduce fever, but some of those common medicines could raise your risk of heart disease or stroke, according to a new report.

Researchers from Aarhus University Hospital in Denmark recently conducted a study, published in the British Medical Journal, to explore the cardiovascular risks associated with diclofenac, a traditional non-steroidal anti-inflammatory drug (NSAID).

To do so, they used national registry data that included information on 6.3 million adults in Denmark. The participants, aged 46 to 56, were split into groups with low, moderate or high baseline cardiovascular risk and were followed for 20 years from 1996 until 2016.

Researchers found that, within 30 days of starting diclofenac, there was an increased rate of major adverse cardiovascular events, such as irregular heart beat or flutter, ischemic stroke, heart failure and heart attack, compared with those starting other traditional NSAIDs.

In fact, the risk of having an adverse cardiovascular event rose by 50 percent among those who took diclofenac, compared with those who had not.

Furthermore, they said there was also a relationship between diclofenac and an increased rate of cardiac death and upper gastrointestinal bleeding.

“Treatment of pain and inflammation with NSAIDs may be worthwhile for some patients to improve quality of life despite potential side effects,” the team wrote in a statement. “Considering its cardiovascular and gastrointestinal risks, however, there is little justification to initiate diclofenac treatment before other traditional NSAIDs.”

The scientists acknowledged the study was observational. However, they noted their sample size was larger than most previous analyses on similar topics.

A 2018 study of 57,000 people in Taiwan, published in the British Journal of Clinical Pharmacology, revealed that some prescription pain relievers, such as ibuprofen and naproxen, may be linked to irregular heartbeat.

Another study published in March 2017, which analyzed nearly 30,000 patients, concluded that the consumption of any kind of NSAIDs such as ibuprofen could boost the risk of heart attack by 31 percent.

TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.